I agree that this site is using cookies. You can find further informations here.
X
Hanes, Vladimir
42  results:
Search for persons X
?
1

A Review of the Totality of Evidence in the Development of ..:

Cobb, Patrick ; Niederwieser, Dietger ; Cohen, Stanley...
Immunotherapy.  14 (2022)  9 - p. 727-740 , 2022
Link: https://doi.org/10.2217/..
 
?
2

Is weight-based IV dosing of trastuzumab preferable to SC f..:

Kolberg, Hans-Christian ; Jackisch, Christian ; Hurvitz, Sara A....
The Breast.  57 (2021)  - p. 95-103 , 2021
Link: https://doi.org/10.1016/..
 
?
3

A randomized, double-blind, single-dose study (LAVENDER) to..:

Hanes, Vladimir ; Chow, Vincent ; Stewart, Tina.
Cancer Chemotherapy and Pharmacology.  88 (2021)  5 - p. 879-886 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Totality of Evidence Supporting the Use of ABP 980, a Trast..:

Kolberg, Hans-Christian ; Demetriou, Georgia Savva ; Hanes, Vladimir
Oncology and Therapy.  9 (2021)  1 - p. 225-238 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Wom..:

Kolberg, Hans-Christian ; Colleoni, Marco ; Demetriou, Georgia Savva...
Drug Safety.  43 (2020)  3 - p. 233-242 , 2020
Link: https://doi.org/10.1007/..
 
?
6

The Totality of Evidence and Use of ABP 215, a Biosimilar t..:

Goldschmidt, Jerome ; Hanes, Vladimir
Oncology and Therapy.  9 (2020)  1 - p. 213-223 , 2020
Link: https://doi.org/10.1007/..
 
?
7

Correction to: Efficacy and Safety of ABP 798: Results from..:

Niederwieser, Dietger ; Hamm, Caroline ; Cobb, Patrick...
Targeted Oncology.  15 (2020)  6 - p. 807-807 , 2020
Link: https://doi.org/10.1007/..
 
?
8

A randomized, double‐blind, single‐dose, three‐arm, paralle..:

Chow, Vincent ; Pan, Jean ; Chien, David..
European Journal of Haematology.  105 (2020)  1 - p. 66-74 , 2020
Link: https://doi.org/10.1111/..
 
?
9

Efficacy and Safety of ABP 798: Results from the JASMINE Tr..:

Niederwieser, Dietger ; Hamm, Caroline ; Cobb, Patrick...
Targeted Oncology.  15 (2020)  5 - p. 599-611 , 2020
Link: https://doi.org/10.1007/..
 
?
10

Totality of evidence in the development of ABP 215, an appr..:

Thomas, Michael ; Thatcher, Nick ; Goldschmidt, Jerome...
Immunotherapy.  11 (2019)  15 - p. 1337-1351 , 2019
Link: https://doi.org/10.2217/..
 
?
11

Totality of Scientific Evidence in the Development of ABP 9..:

Kolberg, Hans-Christian ; Colleoni, Marco ; Santi, Patricia...
Targeted Oncology.  14 (2019)  6 - p. 647-656 , 2019
Link: https://doi.org/10.1007/..
 
?
12

Phase 3 LILAC study sets standard for clinical evaluation o..:

Kolberg, Hans-Christian ; von Minckwitz, Gunter ; Hanes, Vladimir
Oncotarget.  10 (2019)  1 - p. 8-9 , 2019
Link: https://doi.org/10.18632..
 
?
13

Biosimilars: What the Oncologist should Know:

Thill, Marc ; Thatcher, Nicholas ; Hanes, Vladimir.
Future Oncology.  15 (2019)  10 - p. 1147-1165 , 2019
Link: https://doi.org/10.2217/..
 
?
14

A randomized, single-blind, single-dose study to assess the..:

Hanes, Vladimir ; Chow, Vincent ; Pan, Zhiying.
Cancer Chemotherapy and Pharmacology.  82 (2018)  5 - p. 899-905 , 2018
Link: https://doi.org/10.1007/..
 
?
15

A randomized, single-blind, single-dose study evaluating th..:

Hanes, Vladimir ; Chow, Vincent ; Zhang, Nan.
Cancer Chemotherapy and Pharmacology.  79 (2017)  5 - p. 881-888 , 2017
Link: https://doi.org/10.1007/..
 
1-15